The molecular subtyping and precision medicine in triple-negative breast cancer---based on Fudan TNBC classification
Abstract Triple-negative breast cancer (TNBC) is widely recognized as the most aggressive form of breast cancer, occurring more frequently in younger patients and characterized by high heterogeneity, early distant metastases and poor prognosis. Multiple treatment options have failed to achieve the e...
Main Authors: | Lijuan Weng, Jianliang Zhou, Shenchao Guo, Nong Xu, Ruishuang Ma |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-03-01
|
Series: | Cancer Cell International |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12935-024-03261-0 |
Similar Items
-
Precision Medicine and Triple-Negative Breast Cancer: Current Landscape and Future Directions
by: Fokhrul Hossain, et al.
Published: (2021-07-01) -
Reassessment of Reliability and Reproducibility for Triple-Negative Breast Cancer Subtyping
by: Xinjian Yu, et al.
Published: (2022-05-01) -
Immunohistochemistry-based molecular subtyping of triple-negative breast cancer and its prognostic significance
by: Marisa Leeha, et al.
Published: (2023-05-01) -
Research Progress on Molecular Subtyping and Modern Treatment of Triple-Negative Breast Cancer
by: Tong L, et al.
Published: (2023-08-01) -
Artificial Intelligence for Precision Oncology of Triple-Negative Breast Cancer: Learning from Melanoma
by: Ornella Garrone, et al.
Published: (2024-02-01)